Join to View Full Profile
4200 W Memorial RdSuite 206Oklahoma City, OK 73120
Phone+1 405-752-0393
Fax+1 405-752-4242
Dr. Tarpay is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Colorado School of Medicine/National Jewish Health (Adult)Fellowship, Allergy and Immunology, 1984 - 1985
Niagara Falls Memorial Medical CenterInternship, Transitional Year, 1969 - 1970
Semmelweis UniversityClass of 1965
Certifications & Licensure
OK State Medical License 1974 - 2026
CO State Medical License 1985 - 2019
FL State Medical License 2000 - 2017
American Board of Allergy and Immunology Allergy & Immunology
American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
- Fellow (FAAP) American Academy of Pediatrics
Clinical Trials
- Diagnostic Accuracy and Safety of DBV1605 for the Diagnosis of Non-IgE Mediated Cow's Milk Allergy in Children Start of enrollment: 2020 Aug 28
- A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC Start of enrollment: 2018 Dec 21
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 3 citationsAdvantages of video questionnaire in estimating asthma prevalence and risk factors for school children: findings from an asthma survey in American Indian youth.Fawn Yeh, Everett R. Rhoades, Martha Tarpay, June E. Eichner
The Journal of Asthma. 2010-09-10 - 71 citationsInvasive Disease Due to Streptococcus pneumoniae in an Area with a High Rate of Relative Penicillin ResistanceGregory R. Istre, Martha M. Tarpay, Michaelene Anderson, Ami Pryor, David F. Welch
The Journal of Infectious Diseases. 1987-11-01 - 6 citationsThe extended microbiology of group A streptococcal pharyngitis. Observations during a double-blind controlled study of cephalexin twice versus four-times daily.Martha M. Tarpay, S. Chartrand, Melvin I. Marks, A. Cox
Infection. 1984-05-01
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
